1.Gene Therapy for Vascular Disease.
Journal of the Korean Society for Vascular Surgery 2001;17(2):169-184
No abstract available.
Genetic Therapy*
;
Vascular Diseases*
2.Gene Therapy for Cardiovascular Disease.
Yangsoo JANG ; Hyun Young PARK
Korean Circulation Journal 2000;30(6):772-779
No abstract available.
Cardiovascular Diseases*
;
Genetic Therapy*
3.Fc gammaR genetic polymorphisms of periodontal disease in Korean population.
Seung Yun SHIN ; Kyoung Hwa KIM ; Ok Jin PARK ; Yong Moo LEE ; In Chul RHYU ; Kack Kyun KIM ; Young KU ; Hiromasa YOSHIE ; Soo Boo HAN ; Chong Pyoung CHUNG
The Journal of the Korean Academy of Periodontology 2004;34(3):671-681
No abstract available.
Periodontal Diseases*
;
Polymorphism, Genetic*
4.Bullous Annular Erythema as a Cutaneous Sign of Vaginal Stump Adenocarcinoma.
Hye Min LEE ; Joong Sun LEE ; Dae Won KOO
Annals of Dermatology 2013;25(1):131-132
No abstract available.
Adenocarcinoma
;
Erythema
;
Skin Diseases, Genetic
6.Therapeutics in paediatric genetic diseases: Current and future landscape.
Ai Ling KOH ; Saumya Shekhar JAMUAR
Singapore medical journal 2023;64(1):7-16
There are more than 7,000 paediatric genetic diseases (PGDs) but less than 5% have treatment options. Treatment strategies targeting different levels of the biological process of the disease have led to optimal health outcomes in a subset of patients with PGDs, where treatment is available. In the past 3 decades, there has been rapid advancement in the development of novel therapies, including gene therapy, for many PGDs. The therapeutic success of treatment relies heavily on knowledge of the genetic basis and the disease mechanism. Specifically, gene therapy has been shown to be effective in various clinical trials, and indeed, these trials have led to regulatory approvals, paving the way for gene therapies for other types of PGDs. In this review, we provide an overview of the treatment strategies and focus on some of the recent advancements in therapeutics for PGDs.
Child
;
Humans
;
Genetic Diseases, Inborn/therapy*
;
Genetic Therapy
7.Genetics of complex diseases.
Journal of Zhejiang University. Science. B 2006;7(2):167-168
Approaches to the study of the genetic basis of common complex diseases and their clinical applications are considered. Monogenic Mendelian inheritance in such conditions is infrequent but its elucidation may help to detect pathogenic mechanisms in the more common variety of complex diseases. Involvement by multiple genes in complex diseases usually occurs but the isolation and identification of specific genes so far has been exceptional. The role of common polymorphisms as indicators of disease risk in various studies is discussed.
Genetic Diseases, Inborn
;
genetics
;
Genetic Predisposition to Disease
;
Genetic Techniques
;
Humans
;
Inheritance Patterns
;
Linkage Disequilibrium
;
Models, Genetic
;
Polymorphism, Genetic
;
Risk Factors
8.A Case of Waardenburg`s Syndrome.
Dae Won LEE ; Jong Hoon LEE ; Moo Hwan CHANG
Journal of the Korean Ophthalmological Society 1997;38(12):2247-2250
Waardenburg`s syndrome is a rare hereditary disease, which is characterized by dystopia canthorum, hypochromic heterochromic iridum, sensorineural deafness,high and broad nasal bridge, white forelock and premature graying. We present a case of 27 year old woman with Waardenburg`s syndrome. She has characteristic features such as dystopia canthorum, broad and high nasal bridge, confluent eyebrow(synophrys), hypochromic heterochromic iridum, depigmented fundus and premature graying.
Adult
;
Female
;
Genetic Diseases, Inborn
;
Humans
10.Identify the \xdf-thalassemia mutation spectrum in the North of Vietnam
Hoa Khanh Bach ; Cuong Quoc Nguyen ; Luan Thanh Nguyen
Journal of Medical Research 2007;49(3):21-24
Background: \u03b2-thalassemia is a hereditary disease caused by disorder in \u03b2-globin chain synthesis process. In this research, multiplex-PCR was used in combination with blood chemistry assays and clinical symptoms to detect \u03b2-globin mutations. Objectives: (1) to identify the \u03b2-thalassemia mutation spectrum in the North of Vietnam; (2) to determine the relation between biochemistry values and types of mutations. Subject and methods: Blood samples collected from 60 pediatric patients were used in screening assays (hemoglobin counting, red blood cell counting, hematocrit\ufffd? and multiplex-PCR to detect 6 point mutations with high prevalence in the region. Results: \r\n', u'(1) Of 60 blood samples collected from pediatric patients, 30 (50%) had mutation in codon 17 (A\u2192T), 6 (10%) had a frameshift mutation in codons 41/42 and 4 (6%) had both types of these mutations; (2) The average onset time in patients with FS 41/42 mutation was earlier than that of patients with codon 17 (A\u2192T) mutation, whereas transfusion interval did not differ significantly among these patients; (3) Mean corpuscular volume (MCV) was lower in patients with homozygous mutations (\u03b2o) (average 64.8) than in those with heterozygous mutations (\u03b2+) (average 72.7). Conclusions: (1) multiplex-PCR is an effective technique in identifying the mutation spectrum of \u03b2-globin gene in the North of Vietnam; (2) Biochemistry assays should be associated with molecular techniques in diagnose of \u03b2-thalassemia\r\n', u'\r\n', u'\r\n', u'
beta-Thalassemia
;
Thalassemia
;
Genetic Diseases
;
Inborn
;
Mutation